Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Oncology Institute, Inc. (TOI)

$5.13 +5.56% NASDAQ: TOI · 15-min delayed
  • CERRITOS, California
  • Public · NASDAQ: TOI
  • 641 employees
$497.9MMarket cap
$502.7MRevenue · FY2025
-$60.6MNet income
641Employees
TOINASDAQ
2021IPO

About Oncology Institute, Inc.

The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$502.7M
Net income
-$60.6M
Total assets
$164.7M
Market cap
$497.9M

Source: SEC EDGAR · updated Jun 8, 2026

NASDAQ: TOI
$5.13 +5.56%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$2.38 $6.28

52-week range

Market cap
$497.9M
Shares outstanding
97.1M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Nov 15, 2021

Oncology Institute, Inc. (TOI) Stock Price

  • Reported a net loss of $60.6M in FY2025.
  • Trading 18% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Oncology Institute, Inc..

Write a review
Newsroom

News about Oncology Institute, Inc.

News & sentiment via Polygon.io

FAQ

Oncology Institute, Inc.: frequently asked questions

Is Oncology Institute, Inc. an American company?

Oncology Institute, Inc. is a US-based company headquartered in Cerritos, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Oncology Institute, Inc. headquartered?

Oncology Institute, Inc. is headquartered in Cerritos, California, United States.

Is Oncology Institute, Inc. publicly traded?

Yes — Oncology Institute, Inc. is a publicly traded company. Its stock trades under the ticker symbol TOI on the NASDAQ.

What does Oncology Institute, Inc. do?

Oncology Institute, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →